Diabetes Drug Linked to Higher Risk of Death
Monday, November 24, 2008 - 20:14
in Health & Medicine
Patients taking rosiglitazone, sold under the brand name Avandia, were more likely to suffer heart failure and to die than those taking a similar drug, according to a new study.